Iterum Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference Feb 19, 2020
Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors Jan 17, 2020
Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infection Dec 26, 2019
Iterum Therapeutics Announces Topline Results from Phase 3 Clinical Trial of Oral and IV Sulopenem for the Treatment of Complicated Intra-abdominal Infections Dec 10, 2019
Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection Nov 18, 2019
